Dopamine Hydrochloride Injec · #8 of 35 active shortages by FDA posting duration
Brand: DOPAMINE HYDROCHLORIDE IN DEXTROSE
FDA lists Dopamine Hydrochloride Injec as Active Shortage (Hospira, Inc., a Pfizer Company).
Availability on file: Unavailable
Dopamine Hydrochloride Injection: Active Shortage
Unavailable 12 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Dopamine Hydrochloride Injection
- Manufacturer
- Hospira, Inc., a Pfizer Company
- Dosage Form
- Injection
- Presentation
- Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 800 mg/500 mL (1.6 mg/1 mL) (NDC 0409-7809-24)
- Package NDC
- 0409-7809-24
Status & Timeline
- Status
- Active Shortage
- Availability
- Unavailable
- First Reported
- Nov 6, 2017
- Last Updated
- Mar 13, 2026
- Therapeutic Category
- Cardiovascular
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Next Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay
Full Drug Profile
dopamine
Side effects, interactions, warnings & more
Nearby, Other Dopamine Shortage Records
Dopamine Hydrochloride Injection
Hospira, Inc., a Pfizer Company
Injection
Dopamine Hydrochloride Injection
Hospira, Inc., a Pfizer Company
Injection
Dopamine Hydrochloride Injection
Hospira, Inc., a Pfizer Company
Injection
Dopamine Hydrochloride Injection
Hospira, Inc., a Pfizer Company
Injection
Dopamine Hydrochloride Injection
Hikma Pharmaceuticals USA, Inc.
Injection
Dopamine Hydrochloride Injection
Hikma Pharmaceuticals USA, Inc.
Injection
FDA reason on file: Next Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay. General shortage guidance lives on the tracker hub.